Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

APOA2 Antikörper

APOA2 Reaktivität: Human WB, IHC (p), IP, IHC (fro), EIA Wirt: Ziege Polyclonal unconjugated
Produktnummer ABIN116542
  • Target Alle APOA2 Antikörper anzeigen
    APOA2 (Apolipoprotein A-II (APOA2))
    Reaktivität
    • 79
    • 37
    • 13
    • 9
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Human
    Wirt
    • 67
    • 12
    • 7
    • 2
    • 2
    • 1
    Ziege
    Klonalität
    • 75
    • 16
    Polyklonal
    Konjugat
    • 38
    • 12
    • 8
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser APOA2 Antikörper ist unkonjugiert
    Applikation
    • 43
    • 31
    • 25
    • 14
    • 13
    • 9
    • 9
    • 9
    • 8
    • 7
    • 6
    • 4
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunoprecipitation (IP), Immunohistochemistry (Frozen Sections) (IHC (fro)), Enzyme Immunoassay (EIA)
    Spezifität
    This product has been prepared by Immunoaffinity Chromatography using immobilized antigens followed by extensive cross-adsorption against other apoLipoproteins and human serum proteins to remove any unwanted specificities. Typically less than 1 % cross reactivity against other types of apoLipoprotein was detected by ELISA against purified standards. This antibody reacts with ApoLipoprotein A-II and has negligible cross-reactivity with Type A-I, B, C-I, C-II, C-III, E and J apoLipoproteins. Non-specific cross reaction of anti-apoLipoprotein antibodies with other Human serum proteins is negligible.
    Aufreinigung
    Immunoaffinity Chromatography.
    Immunogen
    ApoLipoprotein Type A-II was isolated from Human plasma by Density Gradient Centrifugation followed by HPLC purification.
    Top Product
    Discover our top product APOA2 Primärantikörper
  • Applikationshinweise
    This Apo AII antibody R1031P has been used for indirect trapping ELISA for quantitation ofantigen in serum using a standard curve, for Immunoprecipitation and Western blotting forhighly sensitive qualitative analysis. Recommended Dilutions: ELISA: 1/5,000-1/10,000. Immunoprecipitation: 1/100. Western blot: 1/5,000-1/10,000. Immunohistochemistry: 1: /50-1/200.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    1.0 mg/mL (by UV absorbance at 280 nm)
    Buffer
    0.125 M Sodium Borate, 0.075 M Sodium Chloride, 0.005 M EDTA, pH 8.0 and 0.01 % Sodium Azide as preservative.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Handhabung
    Avoid repeated freezing and thawing. This product is photosensitive and should be protected from light
    Lagerung
    4 °C/-20 °C
    Informationen zur Lagerung
    Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
  • Target
    APOA2 (Apolipoprotein A-II (APOA2))
    Andere Bezeichnung
    Apolipoprotein A II (Apo AII) (APOA2 Produkte)
    Synonyme
    Apo-AII antikoerper, ApoA-II antikoerper, apoAII antikoerper, Alp-2 antikoerper, ApoAII antikoerper, Apoa-2 antikoerper, Hdl-1 antikoerper, APOAII antikoerper, apoa2 antikoerper, apoA-II antikoerper, cb1032 antikoerper, wu:fb57h11 antikoerper, zgc:193613 antikoerper, apolipoprotein A2 antikoerper, apolipoprotein A-II antikoerper, APOA2 antikoerper, Apoa2 antikoerper, apoa2 antikoerper
    Hintergrund
    Apolipoprotein A II is the second most abundant protein of the high density lipoprotein particles. The apolipoprotein A II gene consists of 4 exons and 3 introns. The four exons encode the 5' untranslated region, pre peptide, a short N terminal domain and a C terminal domain composed of a variable number of lipid binding amphipathic helices. Familial apolipoprotein A II deficiency may result from a splice junction alteration which blocks splicing of intron 3 from the primary transcript and result in the formation of a non functional mRNA.Synonyms: APOA2, Apo-AII, ApoA-II, Apolipoprotein A-II, Apolipoprotein A2
    Gen-ID
    336
    NCBI Accession
    NP_001634
    UniProt
    P02652
    Pathways
    Regulation of Lipid Metabolism by PPARalpha, Production of Molecular Mediator of Immune Response, Negative Regulation of Transporter Activity, Lipid Metabolism
Sie sind hier:
Kundenservice